Protective immunity after recovery from SARS-CoV-2 infection.
作者信息
Kojima Noah, Klausner Jeffrey D
机构信息
Department of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.
Departments of Population Health and Public Health Sciences and Medicine, Keck School of Medicine, University Southern California, Los Angeles, CA, USA.
出版信息
Lancet Infect Dis. 2022 Jan;22(1):12-14. doi: 10.1016/S1473-3099(21)00676-9. Epub 2021 Nov 8.
Abstract
摘要
相似文献
1
Protective immunity after recovery from SARS-CoV-2 infection.新型冠状病毒感染康复后的保护性免疫。
Lancet Infect Dis. 2022 Jan;22(1):12-14. doi: 10.1016/S1473-3099(21)00676-9. Epub 2021 Nov 8.
2
SARS-CoV-2 reinfection in a cancer patient with a defective neutralizing humoral response.一名具有缺陷性中和体液反应的癌症患者出现严重急性呼吸综合征冠状病毒2型再次感染。
J Med Virol. 2021 Dec;93(12):6444-6446. doi: 10.1002/jmv.27200. Epub 2021 Jul 20.
3
Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection.COVID-19 疾病的恢复情况和免疫：预测再次感染潜力的新策略。
J Adv Res. 2021 Jul;31:49-60. doi: 10.1016/j.jare.2020.12.013. Epub 2021 Jan 5.
4
Symptomatic reinfection of SARS-CoV-2 with spike protein variant N440K associated with immune escape.出现症状的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）再感染，与刺突蛋白变体N440K相关，伴有免疫逃逸。
J Med Virol. 2021 Jul;93(7):4163-4165. doi: 10.1002/jmv.26997. Epub 2021 Apr 13.
5
Correlates of protection from SARS-CoV-2 infection.针对新型冠状病毒2感染的保护相关因素。
Lancet. 2021 Apr 17;397(10283):1421-1423. doi: 10.1016/S0140-6736(21)00782-0. Epub 2021 Apr 9.
6
Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission.中和抗体在 SARS-CoV-2 再感染和传播中的关键作用。
Emerg Microbes Infect. 2021 Dec;10(1):152-160. doi: 10.1080/22221751.2021.1872352.
7
SARS-CoV-2 Reinfection in a Healthcare Worker Despite the Presence of Detectable Neutralizing Antibodies.SARS-CoV-2 再感染，尽管存在可检测的中和抗体。
Viruses. 2021 Apr 12;13(4):661. doi: 10.3390/v13040661.
8
SARS-CoV-2 infection induces protective immunity and limits transmission in Syrian hamsters.SARS-CoV-2 感染可诱导叙利亚仓鼠产生保护性免疫，并限制其传播。
Life Sci Alliance. 2021 Feb 11;4(4). doi: 10.26508/lsa.202000886. Print 2021 Apr.
9
Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies.轻度 SARS-CoV-2 感染与再感染无关，并提供持久的刺突、核衣壳和病毒中和抗体。
Microbiol Spectr. 2021 Oct 31;9(2):e0008721. doi: 10.1128/Spectrum.00087-21. Epub 2021 Sep 1.
10
Why does the Omicron sub-variant spread faster than the original?为什么奥密克戎亚变体的传播速度比原始毒株更快？
Nature. 2022 Feb;602(7898):556-557. doi: 10.1038/d41586-022-00471-2.
引用本文的文献
1
What Lessons can Be Learned From the Management of the COVID-19 Pandemic?从新冠疫情管理中可以吸取哪些教训？
Int J Public Health. 2025 May 30;70:1607727. doi: 10.3389/ijph.2025.1607727. eCollection 2025.
2
Differential reactivity of SARS-CoV-2 S-protein T-cell epitopes in vaccinated versus naturally infected individuals.接种疫苗者与自然感染者中SARS-CoV-2刺突蛋白T细胞表位的差异反应性。
Clin Transl Immunology. 2025 May 6;14(5):e70031. doi: 10.1002/cti2.70031. eCollection 2025 May.
3
Impact of vaccination on Omicron's escape variants: Insights from fine-scale modelling of waning immunity in Hong Kong.疫苗接种对奥密克戎逃逸变体的影响：来自香港免疫力下降精细尺度模型的见解
Infect Dis Model. 2024 Sep 16;10(1):129-138. doi: 10.1016/j.idm.2024.09.006. eCollection 2025 Mar.
4
Mathematical Modeling of SARS-CoV-2 Omicron Wave under Vaccination Effects.接种疫苗影响下的新冠病毒奥密克戎毒株浪潮的数学建模
Computation (Basel). 2023 Feb;11(2). doi: 10.3390/computation11020036. Epub 2023 Feb 15.
5
Modelling the impact of hybrid immunity on future COVID-19 epidemic waves.模拟混合免疫对未来 COVID-19 疫情波的影响。
BMC Infect Dis. 2024 Apr 16;24(1):407. doi: 10.1186/s12879-024-09282-4.
6
Effectiveness of COVID-19 vaccines among children 6-11 years against hospitalization during Omicron predominance in Malaysia.COVID-19 疫苗在马来西亚奥密克戎为主导期间对 6-11 岁儿童住院的有效性。
Sci Rep. 2024 Mar 8;14(1):5690. doi: 10.1038/s41598-024-55899-5.
7
Ethical and Legal Debates on Vaccine Infodemics.关于疫苗信息疫情的伦理与法律辩论。
Cureus. 2024 Jan 19;16(1):e52566. doi: 10.7759/cureus.52566. eCollection 2024 Jan.
8
Persistence of T-Cell Immunity Responses against SARS-CoV-2 for over 12 Months Post COVID-19 Infection in Unvaccinated Individuals with No Detectable IgG Antibodies.未接种疫苗且未检测到IgG抗体的个体在感染新冠病毒12个月后针对严重急性呼吸综合征冠状病毒2的T细胞免疫反应持续存在。
Vaccines (Basel). 2023 Nov 27;11(12):1764. doi: 10.3390/vaccines11121764.
9
Risk of SARS-CoV-2 infection and hospitalization in individuals with natural, vaccine-induced and hybrid immunity: a retrospective population-based cohort study from Estonia.自然免疫、疫苗诱导免疫和混合免疫个体感染 SARS-CoV-2 及住院的风险：来自爱沙尼亚的一项基于人群的回顾性队列研究。
Sci Rep. 2023 Nov 21;13(1):20347. doi: 10.1038/s41598-023-47043-6.
10
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19-VISION Network, 10 States, June 2021-March 2023.临床流行病学和接种与未接种 COVID-19 住院成年人重症结局的危险因素-VISION 网络，10 个州，2021 年 6 月至 2023 年 3 月。
Clin Infect Dis. 2024 Feb 17;78(2):338-348. doi: 10.1093/cid/ciad505.
本文引用的文献
1
Similarity of Protection Conferred by Previous SARS-CoV-2 Infection and by BNT162b2 Vaccine: A 3-Month Nationwide Experience From Israel.先前感染 SARS-CoV-2 和 BNT162b2 疫苗所产生的保护效果的相似性：来自以色列的为期 3 个月的全国经验。
Am J Epidemiol. 2022 Jul 23;191(8):1420-1428. doi: 10.1093/aje/kwac060.
2
Incidence of SARS-CoV-2 infection among previously infected or vaccinated employees.既往感染或接种疫苗的员工中 SARS-CoV-2 感染的发生率。
Int J Infect Dis. 2022 May;118:21-23. doi: 10.1016/j.ijid.2022.02.015. Epub 2022 Feb 10.
3
CD8+ T-Cell Responses in COVID-19 Convalescent Individuals Target Conserved Epitopes From Multiple Prominent SARS-CoV-2 Circulating Variants.新冠康复个体中的CD8 + T细胞反应靶向多种主要新冠病毒流行变体的保守表位。
Open Forum Infect Dis. 2021 Mar 30;8(7):ofab143. doi: 10.1093/ofid/ofab143. eCollection 2021 Jul.
4
Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants.针对多种高传染性 SARS-CoV-2 变体的超强效抗体。
Science. 2021 Aug 13;373(6556). doi: 10.1126/science.abh1766. Epub 2021 Jul 1.
5
Previous COVID-19 infection, but not Long-COVID, is associated with increased adverse events following BNT162b2/Pfizer vaccination.既往感染过新冠病毒，但非长期新冠，与接种BNT162b2/辉瑞疫苗后不良事件增加有关。
J Infect. 2021 Sep;83(3):381-412. doi: 10.1016/j.jinf.2021.05.035. Epub 2021 May 29.
6
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans.SARS-CoV-2 感染可诱导人类骨髓浆细胞产生长期存活。
Nature. 2021 Jul;595(7867):421-425. doi: 10.1038/s41586-021-03647-4. Epub 2021 May 24.
7
Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients Undergoing Serial Laboratory Testing.对连续进行实验室检测的患者中严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）再感染的研究。
Clin Infect Dis. 2022 Jan 29;74(2):294-300. doi: 10.1093/cid/ciab345.
8
SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study.SARS-CoV-2 血清阳性率及健康青年随后的感染风险：一项前瞻性队列研究。
Lancet Respir Med. 2021 Jul;9(7):712-720. doi: 10.1016/S2213-2600(21)00158-2. Epub 2021 Apr 15.
9
Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination.mRNA 疫苗接种后 SARS-CoV-2 初免者和康复者的抗体和记忆 B 细胞反应存在差异。
Sci Immunol. 2021 Apr 15;6(58). doi: 10.1126/sciimmunol.abi6950.
10
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).英格兰抗体阳性与抗体阴性医护人员的 SARS-CoV-2 感染率：一项大型、多中心、前瞻性队列研究（SIREN）。
Lancet. 2021 Apr 17;397(10283):1459-1469. doi: 10.1016/S0140-6736(21)00675-9. Epub 2021 Apr 9.
Zotero 插件